Loading company…
MoleSense develops molecular monitoring technology for maternal and fetal health during pregnancy.
MoleSense is developing molecular monitoring technology to provide expectant mothers and healthcare providers with information on maternal and fetal health. The Lausanne, Switzerland-based company was founded in 2025. In October 2025, it raised EUR 156 K from Venture Kick to validate its wearable technology and pursue regulatory approval.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in